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============

Proteins have been proven to be among the most significant cellular molecules as they participate in most cellular functionalities. Researchers have deployed a variety of experimental methods for the identification of Protein--Protein Interactions (PPIs). The emergence of high-throughput experimental techniques for the prediction of PPIs, revealed a wide range of PPIs in many organisms. This information alongside with information from small scale experimental techniques has been stored in public available databases and repositories. It is well-known that experimental data include many false positive predictions and provide only low coverage on the full interactomes. This fact has led to the design and development of many computational methods for the prediction of PPIs (Theofilatos et al., [@B23]).

The experimental PPI data have been extensively used in many studies during the last decades and their availability gave a significant boost in training new algorithmic models for the prediction of PPIs and in the overall analysis of PPI data.

Despite the promising results of algorithmic solutions for PPIs\' analysis which fostered molecular biology research, in our opinion the research on computational methods for analyzing PPI data has been recently stagnated. Using the online tool MLtrends introduced by Palidwor and Andrade-Navarro ([@B18]) in a preliminary investigation we have observed that the publications related to the search term "*protein--protein interactions" AND analysis* (abstract and title were searched for this term) present a constant increase in absolute numbers. However, when applying normalization by dividing with the total number of annual publications, we observe a relatively stable percentage of publications related PPI analysis in the last decade. In contrast, systems biology publications present a big positive slope in the last decade even when normalized by the total number of annual publications. This diversification shows that even if the actual total number of publications related to PPIs analysis is increasing as the total number of scientific journals is increasing in the last decade, their total impact on the systems biology domain is decreasing. Additionally, only a few PPI based research works have been published lately with significant impact in clinical research and translational bioinformatics.

In this paper, first we summarize the developments on computational analysis of PPI data and second, we present our belief about the future of PPI data analysis emphasizing in presenting the constraints that have delayed the transition from the current methodologies to a holistic bioinformatics approach, for linking biological and clinical data. Specific solutions are also proposed for all these constraints in order to achieve the optimal exploitation of PPI bioinformatics\' approaches.

State-of-the-art and recent advancements of the computational analysis of PPI data {#s2}
==================================================================================

A wide range of computational methodologies and tools have been proposed during the last decade for the analysis of PPI data. These methods are emphasizing on algorithmic solutions for the problems of predicting and scoring PPIs, the construction of PPI networks, the prediction of protein complexes, and the functional annotation of proteins. The results of these solutions have been uploaded to public available databases and many tools have been supplied to the molecular research scientific community enabling the analysis of the PPIs from a single organism in a few days. State of the art computational methods for the prediction of PPI combine information from different sources and have presented adequate classification performance. Recent approaches (Zhang et al., [@B31]; Saha et al., [@B19]; Theofilatos et al., [@B22]) have attempted to overcome the bottlenecks in this PPIs prediction, namely the definition of negative datasets, the feature selection, the class imbalance, the tradeoff between classification performance and interpretability, missing features values and the calculation of a confidence score for every PPI. The advancements on the computational prediction and scoring of PPI enabled the construction of binary PPI networks with increased coverage on the full interactome. Many tools have been developed so far offering efficient and interactive visualization of large PPI networks (Smoot et al., [@B21]; Li et al., [@B13]; Tripathi et al., [@B26]). As a next step, significant results have been extracted from the analysis of PPI graphs. This analysis includes methods for predicting protein complexes (Chen et al., [@B1]) and the functional and topological characterization of proteins (Ma et al., [@B15]). Recent approaches (Nepusz et al., [@B17]; Hanna and Zaki, [@B8]; Theofilatos et al., [@B24]) have attempted to face with some of the remaining challenges for the prediction of protein complexes such as the prediction of overlapping clusters and the management of weighted PPI graphs thus increasing the accuracy having limited prior knowledge for known protein complexes. One of the ultimate goals of PPI data analysis is to functionally characterize proteins and their interactions. The main limitation of protein function prediction until now is that a combined framework to characterize the full proteome functionally of a single organism having a meaningful confidence score for every annotation does not exist. However, with the continued development of new algorithms and the improvement of experimental techniques we strongly believe that this will be achieved in the next few years.

Bottlenecks in computational analysis of PPI data and reasons for its reduced impact in pharmacy and medicine {#s3}
=============================================================================================================

Computational methodologies for the analysis of PPIs undoubtedly contributed to the advancement of systems biology research. In our opinion, however we have reached the point where research on novel computational methods has stagnated and further advancements in systems biology research cannot be achieved solely through the development of more sophisticated algorithmic solutions. Recently, many researchers have suggested that advancements in the field of PPIs research will be facilitated by improved integration of clinical and molecular data, introducing new clinical phenotype data, such as the ones coming from integrated data using the technologies of smart sensors and personalized medicine, in a format manageable to computational approaches (Tiffin et al., [@B25]). The recent advances in other fields of molecular biology, such as the next generation sequencing data and their analysis, has enabled the transformation of traditional bioinformatics to translation bioinformatics. Despite the large availability of works describing specific combinations of datasets to develop tools suitable for disease genes prioritization, "our understanding of how to perform useful predictions using multiple data sources or across biological networks is still rudimentary" (Nabhan and Sarkar, [@B16]), and in particular, to our knowledge, only a few systematic studies focused on the exploitation of integrated network methods in medicine applications (Schaefer et al., [@B20]; Vinayagam et al., [@B27]).

For all these reasons, a new approach and more ambitious objectives should be set for the analysis of PPI data in order to overcome all these limitations, to meet clinical needs and cover the lost space in translation bioinformatics analysis which has been gained by genomics and transcriptomics analysis. The main challenges for PPI analysis according to our opinion, except from the already mentioned data integration task and the linkage of PPI data with clinical data, are the incorporation of environmental information in the PPI data analysis, the extended study of PPIs among different organisms, e.g., host--pathogen interactions, the three dimensional reconstruction of 2D PPI networks for better representation of protein structure, isoforms and spatial information, the design of new methods for biomarker discovery using PPI data and the development of new methods which will facilitate drug discovery using PPI data. In addition, as firstly proposed by Lopes et al. ([@B14]) and adopted by Schaefer et al. ([@B20]) and Furlong ([@B5]), the availability of condition-specific interactomes that are more representative of the interactions of the proteins in a given tissue or under certain conditions will improve the significance of such analysis. This could be done by providing more realistic results, especially for the exploration of human diseases, where the network topology properties of proteins encoded by disease genes in interactomes should be reassessed with spatiotemporal resolution in healthy and disease states.

Traditional PPI analysis\' approaches study physical and functional PPIs without taking into account environmental influences which may strongly affect a PPI or even the formation of a protein complex. Specifically, it is known that the post translational modifications of proteins, which play an important role in enabling them to interact with other proteins, are significantly affected by environmental changes. Moreover, most complex diseases are attributed to generalized disturbances in genetic and proteomic level in cooperation with environmental causes. In order to exploit PPI analysis in medicine application, it should be combined with environmental information and one way to achieve this is the integration of metabolomics data.

Another field of PPI analysis, which has not yet been thoroughly explored, is the study of interactions between proteins from various organisms with a striking example being the interactions of proteins from host and pathogen organisms which play a significant role in the viability of the affected cells. Until recently there existed a lack of large scale efforts to analyze host--pathogen interactions (Krishnadev and Srinivasan, [@B12]). However, these data are now available and a few methods, such as (Kleftogiannis et al., [@B11]), for their analysis have already been published presenting the potential of this field.

One of the most significant new ideas is the one proposed by Garbutt et al. ([@B6]). This idea refers to the prevalent two dimensional format of the PPI graphs which is oversimplified and may lead to loss of information. To take advantage of the dynamic nature of PPI data, a new three dimensional representation should be stated integrating protein structure, conformation, isoforms and spatial information. Several recent research works take advantage of this idea to incorporate atomic-level protein structure information in PPI networks (Das et al., [@B3]) in order to examine the structural principles of disease mutations over a PPI network, or even to elucidate the genetic and molecular mechanisms of underlying human diseases (Wang et al., [@B29]).

One of the ultimate goals of PPI analysis should be the biomarkers\' discovery. PPI networks contain significant information for the cellular mechanisms and functionalities which should be exploited to uncover disturbances in a network level. The traditional methods which attempt to uncover biomarkers from genetic variations or differences in the expression level have limited applicability as they export a large number of biomarkers without being able to locate the cause of the disturbance. When studying diseases in a network level, the variations are smaller and network based biomarkers are most likely to represent the cause of the disease. For this reason, more emphasis should be given to methods for comparing networks and locating biomarkers from the disturbed proteins, protein interactions, and protein complexes. Preliminary reports on methods for biomarkers\' discovery through PPI networks comparison, revealed a new controversial issue (Wang et al., [@B28]). There are some arguing that hubs in PPI networks are most likely to be found as biomarkers and others arguing against. This issue should be further studied and clarified in order to uncover the network metrics which are adequate to be used for biomarker discovery using PPI graphs.

Another field of PPI analysis which should be further reinforced is drug discovery through PPI data. PPI data analysis has a variety of applications in drug discovery so far (Engin et al., [@B4]). An interesting idea to reduce the possible complications of a potential drug is to target proteins which are interacting with the target protein but have reduced significance in the overall network topology or even are leafs of the PPI graph. Even more such ideas are required to be implemented in a novel way to exploit PPI networks and their topological characteristics in the drug design process.

In the last 5 years significant initiatives, such as ELIXIR-Data for Life (Crosswell and Thornton, [@B2]) and Global Alliance for Data Sharing (Hayden, [@B9]), have attempted to promote biological data sharing, provide the adequate infrastructures and bring together molecular biologists, bioinformaticians and clinicians in order to translate life science research mainly to medicine and bioindustries. These initiatives should be even more re-enforced and promoted in order to integrate productively the knowledge and experience of so different fields toward the realization of personalized medicine. These efforts will be eased by the expected universal adoption of electronic medical records standardization and omics translation to clinical medicine (Issa et al., [@B10]). However, the full clinical potential of these initiatives will still remain unexplored until they are formed in a network perspective that place them within the systems medicine context. Protein--protein interaction analysis will by nature play a significant role in this network-perspective formation.

Conclusions {#s4}
===========

In this opinion article we have presented our belief about the future of PPI data analysis emphasizing in presenting the constraints that delayed the transition from the current methodologies to a holistic bioinformatics approach, for linking biological and clinical data. The main constraints that should be surpassed are the incorporation of environmental information, the host--pathogen PPI data analysis and the expansion of the traditional 2D representation of PPI networks with a more flexible and informative 3D one. These constraints are of equal importance and most of them should be surpassed in order to ease the exploitation of PPI analysis in clinical applications. Moreover, we have stated the most significant areas of clinical applications of PPI data analysis which are biomarkers and drug discovery, and we have proposed certain ideas for advancing PPI analysis in these fields. The next few years, a new boost of clinical data is expected through the new electronic health records and data coming from the developing technologies of smart sensors and personalized medicine (Groves et al., [@B7]; Yang et al., [@B30]) and the computational analysis of PPI data should be ready to exploit this boost.
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